Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, including improved gross margins and free cash flow, alongside a significant dividend increase. Although net sales declined, the company shows resilience with robust EBITDA growth and optimistic guidance. The Q&A session reveals management's confidence in sustaining gross margins and navigating promotional challenges. The slight sales decline is offset by new product success and international growth expectations. Overall, the company's strategic initiatives and financial health suggest a positive sentiment, likely leading to a stock price increase over the next two weeks.
Net Sales $1.2 billion, a decline of 4% year-over-year due to softer-than-anticipated industry volumes.
Adjusted EBITDA $231 million, an improvement of 6% year-over-year driven by strong gross margin performance and solid cost controls.
Adjusted EPS $0.63, a growth of 9% year-over-year attributed to healthy earnings growth despite industry challenges.
Gross Margin 41.9%, improved by 200 basis points year-over-year due to favorable commodities, operational efficiencies, and optimized logistics.
Operating Margin (North America) 18.4%, improved by 100 basis points year-over-year driven by gross margin improvement, partially offset by growth initiative investments.
International Sales Growth 1% on a reported basis and 2% on a constant-currency basis, with gross margin improving by 170 basis points to 56.6%.
Free Cash Flow $122 million, the strongest second quarter free cash flow since 2021.
Debt-to-EBITDA Leverage Ratio 2.7 times, within the target range of 2 to 3 times, expected to trend down as the company prepares for the Mattress Firm acquisition.
Capital Expenditures (CapEx) Approximately $140 million, down significantly from prior years, driven by maintenance and growth CapEx.
Quarterly Dividend $0.13, an increase of 18% year-over-year.
New Product Launches: Tempur-Pedic's all-new Adapt products designed to alleviate aches and pains, leveraging innovative Tempur material with a 20% improvement in pressure relief.
Ultra-Premium Product Introduction: ActiveBreeze product, an advanced heating and cooling sleep system priced at approximately $13,800 for a queen, integrates Sleep Tracker AI and drives premium ticket sales.
Market Performance: U.S. business outperformed the market despite a mid-single-digit industry decline, driven by strong brand performance and new product introductions.
International Expansion: International business showed solid growth year-over-year, supported by the rollout of new Tempur mattresses, bed bases, and pillows.
Gross Margin Improvement: Consolidated adjusted gross margin expanded by 200 basis points year-over-year, driven by enhanced supply contracts and improved labor productivity.
Free Cash Flow: Reported $122 million in free cash flow, the strongest second quarter since 2021.
Acquisition Strategy: Successfully executed a new post-closing supply agreement with a medium-sized mattress supplier in preparation for the Mattress Firm acquisition.
Industry Volumes: The company faced a mid-single-digit industry decline in the quarter, which was worse than their anticipated low single-digit decline.
Competitive Pressures: Despite outperforming the market, the company acknowledged the challenges posed by softer-than-anticipated industry volumes.
Supply Chain Challenges: The company is preparing for the Mattress Firm acquisition, which involves executing new supply agreements and navigating ongoing litigation.
Economic Factors: The guidance for 2024 indicates expectations of continued industry headwinds, with U.S. bedding industry unit volumes projected to decline mid-single digits.
Advertising Investments: The company plans to allocate approximately $475 million in advertising spend to support its brands and new products, indicating a significant investment in a challenging market.
Debt Management: The company reported a leverage ratio of 2.7 times, which is within their target range, but they expect to continue deleveraging as they prepare for the Mattress Firm acquisition.
New Product Launches: The introduction of the all-new Adapt products and the ActiveBreeze product, which integrates Sleep Tracker AI, is aimed at enhancing brand perception and driving premium sales.
International Expansion: The international rollout of new Tempur mattresses, bed bases, and pillows is a key driver for growth in international markets.
Advertising Investments: Continued investment in advertising, particularly for the Tempur and Stearns & Foster brands, to support new product launches and drive consumer interest.
Cost Management: Operational efficiencies and enhanced supply contracts have contributed to gross margin improvements.
Mattress Firm Acquisition Preparation: Execution of post-closing supply agreements in preparation for the Mattress Firm acquisition.
Adjusted EPS Guidance: Expected adjusted EPS in the range of $2.45 to $2.65, representing a 6% growth year-over-year.
Sales Growth Expectations: Slight sales growth anticipated in the back half of the year, with full-year sales expected to be consistent with the prior year.
CapEx Projections: CapEx expected to be approximately $140 million, with $110 million for maintenance and $30 million for growth.
Adjusted EBITDA Guidance: Expected adjusted EBITDA of approximately $940 million at the midpoint of the range.
Industry Volume Expectations: 2024 U.S. bedding industry unit volumes expected to decline mid-single digits.
Quarterly Dividend: $0.13, an increase of 18% year-over-year.
Free Cash Flow: $122 million, the strongest second quarter free cash flow since 2021.
Debt-to-EBITDA Leverage: 2.7 times, well within the target range.
2024 Adjusted EPS Guidance: Expected to be in the range of $2.45 to $2.65, representing a 6% growth year-over-year.
Advertising Spend: Approaching $475 million to support leading brands and new products.
Capital Expenditures: Approximately $140 million, with $110 million for maintenance and $30 million for growth.
The earnings call reveals a mix of positive financial performance with net sales, EBITDA, and EPS growth. The increase in quarterly dividends and strong free cash flow are positive signals. However, competitive pressures and operational risks are noted. The Q&A highlights management's optimism about market recovery and growth, particularly in international markets, despite some vagueness in responses. The overall sentiment is positive, with strong financial metrics and optimistic guidance outweighing concerns, likely leading to a positive stock price movement in the short term.
The earnings call highlights strong financial performance, including improved gross margins and free cash flow, alongside a significant dividend increase. Although net sales declined, the company shows resilience with robust EBITDA growth and optimistic guidance. The Q&A session reveals management's confidence in sustaining gross margins and navigating promotional challenges. The slight sales decline is offset by new product success and international growth expectations. Overall, the company's strategic initiatives and financial health suggest a positive sentiment, likely leading to a stock price increase over the next two weeks.
The earnings call summary indicates strong financial performance with positive growth in North American sales and market share gains, despite challenges in international markets. The Q&A section reveals optimism about future gross margin expansion and strategic growth initiatives. Though there are uncertainties regarding the Mattress Firm acquisition, management's confidence in closing the deal and potential capital deployment for share repurchases adds a positive outlook. Overall, the combination of market share gains, expected margin improvements, and strategic growth plans suggests a positive sentiment towards stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.